Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Brain-specific Crmp2 deletion leads to neuronal development deficits and behavioural impairments in mice.

Zhang H, Kang E, Wang Y, Yang C, Yu H, Wang Q, Chen Z, Zhang C, Christian KM, Song H, Ming GL, Xu Z.

Nat Commun. 2016 Jun 1;7. doi: 10.1038/ncomms11773.

2.

Evidence for contribution of common genetic variants within chromosome 8p21.2-8p21.1 to restricted and repetitive behaviors in autism spectrum disorders.

Tao Y, Gao H, Ackerman B, Guo W, Saffen D, Shugart YY.

BMC Genomics. 2016 Mar 1;17:163. doi: 10.1186/s12864-016-2475-y.

3.

Genome-wide significant linkage of schizophrenia-related neuroanatomical trait to 12q24.

Sprooten E, Gupta CN, Knowles EE, McKay DR, Mathias SR, Curran JE, Kent JW Jr, Carless MA, Almeida MA, Dyer TD, Göring HH, Olvera RL, Kochunov P, Fox PT, Duggirala R, Almasy L, Calhoun VD, Blangero J, Turner JA, Glahn DC.

Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):678-86. doi: 10.1002/ajmg.b.32360.

4.

Functional variants in DPYSL2 sequence increase risk of schizophrenia and suggest a link to mTOR signaling.

Liu Y, Pham X, Zhang L, Chen PL, Burzynski G, McGaughey DM, He S, McGrath JA, Wolyniec P, Fallin MD, Pierce MS, McCallion AS, Pulver AE, Avramopoulos D, Valle D.

G3 (Bethesda). 2014 Nov 20;5(1):61-72. doi: 10.1534/g3.114.015636.

5.

Revisiting schizophrenia linkage data in the NIMH Repository: reanalysis of regularized data across multiple studies.

Vieland VJ, Walters KA, Lehner T, Azaro M, Tobin K, Huang Y, Brzustowicz LM.

Am J Psychiatry. 2014 Mar;171(3):350-9. doi: 10.1176/appi.ajp.2013.11121766.

6.

Association study of 167 candidate genes for schizophrenia selected by a multi-domain evidence-based prioritization algorithm and neurodevelopmental hypothesis.

Zhao Z, Webb BT, Jia P, Bigdeli TB, Maher BS, van den Oord E, Bergen SE, Amdur RL, O'Neill FA, Walsh D, Thiselton DL, Chen X, Pato CN; International Schizophrenia Consortium., Riley BP, Kendler KS, Fanous AH.

PLoS One. 2013 Jul 29;8(7):e67776. doi: 10.1371/journal.pone.0067776.

7.

Multiple variants aggregate in the neuregulin signaling pathway in a subset of schizophrenia patients.

Hatzimanolis A, McGrath JA, Wang R, Li T, Wong PC, Nestadt G, Wolyniec PS, Valle D, Pulver AE, Avramopoulos D.

Transl Psychiatry. 2013 May 28;3:e264. doi: 10.1038/tp.2013.33.

8.

Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Light GA, Braff DL.

Am J Psychiatry. 2013 May;170(5):521-32. doi: 10.1176/appi.ajp.2012.12020186.

9.

Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci.

Børglum AD, Demontis D, Grove J, Pallesen J, Hollegaard MV, Pedersen CB, Hedemand A, Mattheisen M; GROUP investigators10., Uitterlinden A, Nyegaard M, Ørntoft T, Wiuf C, Didriksen M, Nordentoft M, Nöthen MM, Rietschel M, Ophoff RA, Cichon S, Yolken RH, Hougaard DM, Mortensen PB, Mors O.

Mol Psychiatry. 2014 Mar;19(3):325-33. doi: 10.1038/mp.2013.2.

10.
11.

Schizophrenia: from epidemiology to rehabilitation.

Mura G, Petretto DR, Bhat KM, Carta MG.

Clin Pract Epidemiol Ment Health. 2012;8:52-66. doi: 10.2174/1745017901208010052.

12.

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.

Liu Q, Jamba M, Patrick C 3rd, Padmanabhan S, Brennan MD.

Pharmacogenomics. 2012 Aug;13(11):1227-37. doi: 10.2217/pgs.12.105.

13.

Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness.

Bigdeli TB, Maher BS, Zhao Z, Oord EJ, Thiselton DL, Sun J, Webb BT, Amdur RL, Wormley B, O'Neill FA, Walsh D, Riley BP, Kendler KS, Fanous AH.

PLoS One. 2011;6(12):e21440. doi: 10.1371/journal.pone.0021440.

14.

Association of C1QB gene polymorphism with schizophrenia in Armenian population.

Zakharyan R, Khoyetsyan A, Arakelyan A, Boyajyan A, Gevorgyan A, Stahelova A, Mrazek F, Petrek M.

BMC Med Genet. 2011 Sep 28;12:126. doi: 10.1186/1471-2350-12-126.

15.

Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia.

Tang B, Thornton-Wells T, Askland KD.

PLoS One. 2011 Apr 29;6(4):e19073. doi: 10.1371/journal.pone.0019073.

16.

Linkage analysis of plasma dopamine β-hydroxylase activity in families of patients with schizophrenia.

Cubells JF, Sun X, Li W, Bonsall RW, McGrath JA, Avramopoulos D, Lasseter VK, Wolyniec PS, Tang YL, Mercer K, Pulver AE, Elston RC.

Hum Genet. 2011 Nov;130(5):635-43. doi: 10.1007/s00439-011-0989-6.

17.

CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity.

Onaivi ES, Ishiguro H, Gu S, Liu QR.

J Psychopharmacol. 2012 Jan;26(1):92-103. doi: 10.1177/0269881111400652. Review.

18.

Contribution of nonprimate animal models in understanding the etiology of schizophrenia.

Lazar NL, Neufeld RW, Cain DP.

J Psychiatry Neurosci. 2011 Jul;36(4):E5-29. doi: 10.1503/jpn.100054. Review.

19.

Genetics in schizophrenia: where are we and what next?

Tiwari AK, Zai CC, Müller DJ, Kennedy JL.

Dialogues Clin Neurosci. 2010;12(3):289-303. Review.

20.

Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE, Irmansyah, Holmans PA, Escamilla M, Wildenauer DB, Williams NM, Laurent C, Mowry BJ, Brzustowicz LM, Maziade M, Sklar P, Garver DL, Abecasis GR, Lerer B, Fallin MD, Gurling HM, Gejman PV, Lindholm E, Moises HW, Byerley W, Wijsman EM, Forabosco P, Tsuang MT, Hwu HG, Okazaki Y, Kendler KS, Wormley B, Fanous A, Walsh D, O'Neill FA, Peltonen L, Nestadt G, Lasseter VK, Liang KY, Papadimitriou GM, Dikeos DG, Schwab SG, Owen MJ, O'Donovan MC, Norton N, Hare E, Raventos H, Nicolini H, Albus M, Maier W, Nimgaonkar VL, Terenius L, Mallet J, Jay M, Godard S, Nertney D, Alexander M, Crowe RR, Silverman JM, Bassett AS, Roy MA, Mérette C, Pato CN, Pato MT, Roos JL, Kohn Y, Amann-Zalcenstein D, Kalsi G, McQuillin A, Curtis D, Brynjolfson J, Sigmundsson T, Petursson H, Sanders AR, Duan J, Jazin E, Myles-Worsley M, Karayiorgou M, Lewis CM.

Mol Psychiatry. 2009 Aug;14(8):774-85. doi: 10.1038/mp.2008.135.

Items per page

Supplemental Content

Support Center